<DOC>
	<DOCNO>NCT00234871</DOCNO>
	<brief_summary>The primary objective study determine trandolapril/verapamil ( Tarka速 ) superior amlodipine/benazepril ( Lotrel速 ) reduction albuminuria hypertensive subject Type 2 diabetes mellitus ( DM ) diabetic nephropathy</brief_summary>
	<brief_title>Tarka速 vs. Lotrel速 Hypertensive , Diabetic Subjects With Renal Disease ( TANDEM )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Trandolapril</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>Diabetes Hypertension Albuminuria Type 1 DM . Subject severe hepatic dysfunction Screening determine liver function test : Bilirubin &gt; 2.0 mg/dL . ALT and/or AST &gt; 3 time upper limit normal . Subject poorly control diabetes , base HbA1c &gt; 10 % Screening . Subject nondiabetic renal disease . Subject hypersensitivity ACE inhibitor , CCB , torsemide sulfonylurea .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Proteinuria</keyword>
	<keyword>Tarka</keyword>
	<keyword>Lotrel</keyword>
</DOC>